help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miehle, K.
Right arrow Articles by Koch, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miehle, K.
Right arrow Articles by Koch, C. A.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Pancreatic Cancer
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 8 3731-3736
Copyright © 2004 by The Endocrine Society


Clinical Case Seminar

Pancreatic Neuroendocrine Tumor with Ectopic Adrenocorticotropin Production upon Second Recurrence

Konstanze Miehle, Andrea Tannapfel, Peter Lamesch, Gudrun Borte, Eva Schenker, Regine Kluge, Rudolf A. Ott, Volker Wiechmann, Martin Koch, Woubet Kassahun, Ralf Paschke and Christian A. Koch

Departments of Endocrinology and Nephrology (K.M., R.P., C.A.K.), Pathology (A.T.), Surgery (P.L., R.A.O., W.K.), Radiology (G.B.), Gastroenterology, Hematology, and Oncology (E.S.), and Nuclear Medicine (R.K.), University of Leipzig, 04103 Leipzig, Germany; Volker Wiechmann: Department of Pathology, St. Georg Hospital (V.W.), 04129 Leipzig, Germany; and Department of Pathology, Charite, Humboldt University of Berlin (M.K.), 10117 Berlin, Germany

Address all correspondence and requests for reprints to: Christian A. Koch, MD, FACP, FACE, Department of Endocrinology and Nephrology, University of Leipzig, Philipp Rosenthalstrasse 27, 04103 Leipzig, Germany. E-mail: kocc{at}medizin.uni-leipzig.de.

We present a 54-yr-old woman with ectopic corticotropin syndrome caused by a neuroendocrine tumor of the pancreas. At initial presentation, the patient suffered from diarrhea, heartburn, and nonspecific abdominal pain. There was no evidence of Cushing’s syndrome. A neuroendocrine tumor in the head of the pancreas with metastases into peripancreatic lymph nodes was diagnosed and completely resected. Fourteen months later, abdominal computed tomography and scintigraphy with 111In-labeled octreotide suggested relapse of the tumor. The patient again had no evidence of Cushing’s syndrome. A second in toto tumor resection was performed. Another 8 months later, the patient developed forgetfulness, depressive episodes, muscle weakness, new-onset hypertension, hypokalemia, plethora, diabetes mellitus, polyuria, and weight loss. Endocrine testing suggested a source of ectopic ACTH production. An octreotide scan showed an intense uptake ventromedial of the left kidney, an area that showed a mass lateral of the superior mesenteric artery on abdominal magnetic resonance imaging. A complete pancreatectomy with splenectomy and left-sided adrenalectomy were performed. At this second relapse, this neuroendocrine tumor clinically had changed its hormonal profile. Immunohistochemically, in contrast to primary tumor and first relapse, we found strong immunostaining for ACTH in tumor cells of the second relapse and a MIB-1 index greater than 20%. To our knowledge, this is the first report describing a pancreatic neuroendocrine tumor that started to secrete ACTH de novo at the time of the second relapse after two former complete tumor resections. This case underscores the pluripotency of neuroendocrine tumor cells and the importance of keeping in mind a possible shift in hormone production during tumor evolution and progression.

Abbreviations: CA, Cancer antigen; CT, computed tomography; MRI, magnetic resonance imaging; MTC, medullary thyroid carcinoma; PRL, prolactin.




This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
C. A KOCH, O. GIMM, A. O VORTMEYER, H. K AL-ALI, P. LAMESCH, R. OTT, R. KLUGE, U. BIERBACH, and A. TANNAPFEL
Does the Expression of c-kit (CD117) in Neuroendocrine Tumors Represent a Target for Therapy?
Ann. N.Y. Acad. Sci., August 1, 2006; 1073: 517 - 526.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
R. L Brown, T. Muzzafar, R. Wollman, and R. E Weiss
A pituitary carcinoma secreting TSH and prolactin: a non-secreting adenoma gone awry.
Eur. J. Endocrinol., May 1, 2006; 154(5): 639 - 643.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society